PSKH1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| protein serine kinase H1 | MIM:177015 | Ensembl:ENSG00000159792 | HGNC:HGNC:9529 | PA33874 | 16q22.1 |
GO terms in PSKH1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | ND | GO:0005575 | cellular_component |
| CC | IDA | GO:0005654 | nucleoplasm |
| CC | IEA | GO:0005789 | endoplasmic reticulum membrane |
| CC | IEA | GO:0005794 | Golgi apparatus |
| CC | IEA | GO:0005815 | microtubule organizing center |
| CC | IEA | GO:0005886 | plasma membrane |
| CC | IEA | GO:0016607 | nuclear speck |
| BP | IEA | GO:0007368 | determination of left/right symmetry |
| BP | IEA | GO:0007507 | heart development |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: PSKH1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD577 | BIX01294 | 2 |
| iGMDRD562 | Navitoclax | 3 |
| iGMDRD398 | Sepantronium | 6 |
| iGMDRD634 | SCHEMBL2608041 | 2 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD889 | Compound 7d-cis | 2 |
| iGMDRD126 | Tipifarnib | 3 |
| iGMDRD474 | Avrainvillamide | 1 |
| iGMDRD318 | PAC-1 | 1 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD289 | Parthenolide | 1 |
| iGMDRD427 | ABT737 | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in PSKH1

